7733 On Other Exchanges
7733 is not on other exchanges.

olympus corp (7733) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OLYMPUS CORP (7733)

Related News

No related news articles were found.

olympus corp (7733) Related Businessweek News

View More BusinessWeek News

olympus corp (7733) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The company offers endoscopic video imaging systems, gastrointestinal/colono/duodeno/broncho endoscopes, endoscopic ultrasound systems, ultrasound endoscopes/probes, ultrasound centers, capsule endoscopy systems, medical information systems, therapeutic peripherals, and ancillary products, as well as cleaning, disinfecting, and sterilization systems; endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, anesthesiology, and otolaryngology; therapeutic and surgical equipment, and peripherals; and endotherapy products. It also provides system biological microscopes, inverted biological microscopes, stereo microscopes, confocal laser scanning microscopes, single-molecule fluorescence detection systems, microscope system equipment, and peripherals; metallurgical microscopes, semiconductor inspection microscopes, flat-panel display inspection systems, laser microscopes, measuring microscopes, microscopic 3-d measurement systems, and peripherals; industrial videoscopes, industrial fiberscopes, industrial rigidscopes, peripherals, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, and x-ray fluorescence and x-ray diffraction analyzers. In addition, the company offers interchangeable lens system digital cameras, compact digital cameras, and digital camera products; lens barrels for digital cameras, and optical materials; IC recorders; and binoculars. Further, it provides biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

34,687 Employees
Last Reported Date: 06/28/17
Founded in 1919

olympus corp (7733) Top Compensated Officers

President & Representative Director
Total Annual Compensation: ¥102.4M
Compensation as of Fiscal Year 2017.
olympus corp
Olympus Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Six Months and Full Year Ending March 31, 2018; Provides Dividend Guidance for the Year Ending March 31, 2018

Olympus Corporation reported consolidated earnings results for the first quarter ended June 30, 2017. For the quarter, the company reported revenue of JPY 171,846 million compared to JPY 168,620 million a year ago. Operating income was JPY 12,707 million compared to JPY 13,364 million a year ago. Profit before tax was JPY 11,924 million compared to JPY 11,314 million a year ago. Net income attributable to owners of the parent was JPY 10,055 million compared to JPY 8,981 million a year ago. Net income per diluted share was JPY 29.37 compared to JPY 26.23 a year ago. Net cash provided by operating activities was JPY 20,138 million compared to JPY 24,887 million a year ago. Purchase of property, plant and equipment was JPY 11,289 million compared to JPY 10,747 million a year ago. Purchase of intangible assets was JPY 5,012 million compared to JPY 2,563 million a year ago. The company revised earnings guidance for the six months and full year ending March 31, 2018. For the six months, the company expects net revenue of JPY 366,000 operating income of JPY 35,000 million, ordinary income of JPY 32,000 million, profit before tax of JPY 32,000 million, net income attributable to shareholders of the parent of JPY 27,000 million or JPY 78.89 per share. For the year ending March 31, 2018, the company expects net revenue of JPY 766,000 operating income of JPY 79,000 million, ordinary income of JPY 79,000 million, profit before tax of JPY 72,000 million, net income attributable to shareholders of the parent of JPY 55,000 million or JPY 160.71 per share. The company provided dividend guidance for the year ending March 31, 2018. For the year, the company expects to pay a dividend of JPY 28.00 against JPY 28.00 per share paid a year ago.

Olympus Corporation, Q1 2018 Earnings Call, Aug 08, 2017

Olympus Corporation, Q1 2018 Earnings Call, Aug 08, 2017

Olympus Launches New 3D Surgical Endoscope

Olympus Corporation has launched ENDOEYE 3D video telescope that supports faster and more precise endoscopic surgery by using 3D imaging to facilitate depth perception. The new product will be launched at the end of June 2017 in Japan. As a minimally invasive surgical practice that enables rapid recovery with less of a burden on the patient, endoscopic surgery in Japan has grown drastically since the 1990s. In recent years, it also has been adopted for difficult procedures such as colectomy and gastrectomy that require a high degree of skill. These are procedures where depth perception is vital for ensuring safe and trouble-free surgery.ENDOEYE 3D is a 3D surgical endoscope that is used in conjunction with the VISERA ELITE II surgical endoscope system launched in March 2017. Its 3D imaging helps make endoscopic surgery faster and more precise by overcoming the difficulties with depth perception that occur when viewing internal organs on flat 2D images. It has also been designed for easier use, with the ability to maintain image orientation when the endoscope is rotated. The company previous 3D endoscope system required two video system centers, a 3D video processor, and a light source. In contrast, this new product can achieve 3D imaging by connecting to the VISERA ELITE II's single video system center that consolidates all of these functions in one box. This reduction in the number of devices makes the product easier for medical staff to handle and also reduces the initial investment cost. In addition to 3D, VISERA ELITE II supports a wide variety of imaging modalities including IR3, 2D, and NBI4. It also has extensive compatibility with various camera heads and videoscopes and this helps realize efficient system operation at hospitals because it serves as a universal surgical platform. Main features of 3D Surgical Endoscope include: 3D imaging helps improve surgical precision and reduce operation time by overcoming the difficulties with depth perception that occur when viewing internal organs using flat 2D images. It does this by, for example, providing a clear indication of needle orientation to assist with needle insertion accuracy when suturing. Moreover, the two high-resolution CCD image sensors fitted at the videoscope tip provide rich 3D images with high definition; and it is important to maintain ease of viewing during endoscopic surgery by repositioning or rotating the endoscope. Despite using two tip CCDs, the new model features a proprietary mechanism that keeps the image orientation on the monitor the same even when the endoscope is rotated. This world-first technique provides rich 3D imaging with the same operational feel as conventional 2D models.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

7733 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7733.
View Industry Companies

Industry Analysis


Industry Average

Valuation 7733 Industry Range
Price/Earnings 16.8x
Price/Sales 1.8x
Price/Book 3.3x
Price/Cash Flow 11.2x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.